drugset / Trial / NCT00666796

A Study to Assess the Pharmacodynamic Interaction Between Gabapentin and Ethanol in Healthy Subjects

NCT00666796

Phase 4 Completed 20 enrolled Viatris Inc.
RandomizedCrossoverTriple-blindBasic science

Summary

The purpose of this study is to assess the pharmacodynamic interaction between gabapentin and ethanol

Timeline

Start
2005-04
Primary completion
Completion
2005-05

Drugs

EvaluationDrugModalityDoseRoute
Subject Alcohol Other / unclassified 0.7 g/kg Oral
Subject Gabapentin Small molecule 500 mg Oral

Indications